SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HCV: THERAPEUTICS AND PROGRESS TOWARD ELIMINATION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
REINFECTION WITH THE HEPATITIS C VIRUS IN MEN WHO HAVE SEX WITH MEN (ABSTRACT
439)
Christoph Boesecke
University Hospital Bonn, Bonn, Germany
COST-EFFECTIVENESS OF HCV TESTING STRATEGIES FOR HCV ELIMINATION AMONG MSM IN THE US (ABSTRACT
440)
Natasha Martin
UC San Diego, la jolla, CA, USA
HIV/HCV COINFECTION TRENDS IN SPAIN (2015-2019) (ABSTRACT
441)
Juan Berenguer
Hospital General Universitario Gregorio Marañón, Madrid, Spain
NO CHANGE IN INCIDENCE OF RECENTLY ACQUIRED HCV IN HIV+ MSM IN GERMANY (NOCO COHORT) (ABSTRACT
442)
Patrick Ingiliz
Saint Antoine Hospital, Paris, France
ADEQUATE DACLATASVIR EXPOSURES IN CHILDREN 14-35 KG WITH AVAILABLE ADULT FORMULATIONS (ABSTRACT
444)
Tim R Cressey
Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
FAILURE TO ACHIEVE HCV MICROELIMINATION AMONG PLWH IN SPAIN (ABSTRACT
445)
Alejandro Gonzalez-Serna
Virgen de Valme University Hospital, Sevilla, Spain
SELF-TESTING FOR HCV: MULTICOUNTRY EVIDENCE ON USABILITY AND ACCEPTABILITY (ABSTRACT
446)
Elena Ivanova Reipold
Foundation for Innovative New Diagnostics, Geneva, Switzerland
DRUG-USE STIGMA AND HEPATITIS C VIRUS INFECTION AMONG PWID IN INDIA (ABSTRACT
447)
Eshan U Patel
Johns Hopkins University, Baltimore, MD, USA
ACCESS TO HCV CARE AMONG HIV/HCV-COINFECTED PEOPLE WHO INJECT DRUGS ACROSS CANADA (ABSTRACT
448)
Charlotte Lanièce Delaunay
McGill University, Montreal, Canada
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
9 of
9
|
